Skip to Content

Publications

CEND affiliates are research leaders - publishing new discoveries to accelerate progress against neglected and emerging diseases.

Publications

Publications

Hyaluronan Ameliorates Viral Pneumonia in Mice and Humans by Inhibiting E2F1 Transcription Factor

Vandy P Stober , Carol S. Trempus , Flavia Galdi , Negin P. Martin , Wesley Gladwell , Michael Cronce , Jeffery S. Cox , Jay D. Keasling , Jonathan Budzik , Shih-Heng Chen , Yosuke Sakamachi , Jian-Liang Li , Christopher A. McGee , Daniel J. Zaccaro , Jane S. Der , Charles J. Tucker , Erica Scappini , Javier Campos Gomez , Steven M. Rowe , Mary K. Cowman , Christina M. Barkauskas , Patty J. Lee , Matthew R Markovetz , Brian Button , David B. Hill , Dorothea A. Erxleben , Adam R. Hall , Jian Liu , Yongmei Xu , Claudio Pedone , Raffaele Antonelli-Incalzi , Sadis Matalon , Rashmin C. Savani , and Stavros Garantziotis 

Hyaluronan Ameliorates Viral Pneumonia in Mice and Humans by Inhibiting E2F1 Transcription Factor

Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study

a,*, b, b, a, a, c, d, e, f, f, a, b

aFrench Research Institute for Development—Unité Mixte Internationale 233 and French National Institute of Health and Medical Research—Unit 1175, University of Montpellier Montpellier, France
bCentre for Research on Filariasis and other Tropical Diseases, Yaounde, Cameroon
cDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA
dDepartment of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands
eDepartment of Bioengineering and Biophysics Programme, University of California, Berkeley, CA, USA
fLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study

Prevalence of Antimicrobial Resistance Genes and Integrons in Commensal Gram-Negative Bacteria in a College Community

Julia Rubin (1), Kaitlyn Mussio(2), Yuqi Xu (2), Joy Suh(1), and Lee W. Riley(1)

(1) Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA.

(2) Department of Biochemistry and Molecular Biology, College of Life Sciences, Peking University, Beijing, China.

 

Prevalence of Antimicrobial Resistance Genes and Integrons in Commensal Gram-Negative Bacteria in a College Community

Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya

Aubree Gordon 1Lionel Gresh 2Sergio Ojeda 2Gerardo Chowell 3Karla Gonzalez 2 4Nery Sanchez 2Saira Saborio 2 4Juan Carlos Mercado 2 4Guillermina Kuan 2 5Angel Balmaseda 2 4Eva Harris 1 6

  • 1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor.

  • 2Sustainable Sciences Institute, Managua, Nicaragua.

  • 3Georgia State University, Atlanta.

  • 4Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia.

  • 5Centro de Salud Sócrates Flores Vivas, Ministerio de Salud, Managua, Nicaragua.

  • 6Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley.

Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya

Screening our FDA-Approved and Bioactive Compounds Library for Antiviral Activity against SARS-CoV‑2

Scott B. Biering, Erik Van Dis, Eddie WehriLivia H. Yamashiro,/ Xammy Huu Wrynla, Claire Dugast-Darzacq, Thomas G. W. Graham, Julien R. Stroumza, Guillaume R. Golovkine, Allison W. Roberts, Daniel M. Fines, Jessica N. Spradlin, Carl C. Ward, Teena BajajDustin Dovala, Ursula Schulze-Gamen, Ruchika Bajaj, Douglas M. Fox, Melanie Ott, Niren Murthy, Daniel K. Nomura, Julia Schaletzky, *Sarah A. Stanley*

Screening our FDA-Approved and Bioactive Compounds Library for Antiviral Activity against SARS-CoV‑2